Dr. Peter Schmid

Dr. Peter Schmid

Company: Barts Cancer Institute

Job title: Professor of Cancer Medicine

Seminars:

Immuno-Oncology in Triple Negative Breast Cancer & Future Perspectives for Other Subtypes 7:10 pm

Read more

day: Clinical Implications of Novel Immuno-Oncology Biomarkers

Panel Discussion: Precision Medicine Beyond Targeted Therapy: an EU Perspective 7:30 pm

Addressing the different challenges and advantages of novel liquid diagnostic approaches Discussing large opportunities in the Immuno-Oncology field when it comes to developing drugs with high efficacy in both early and late-stage cancer Unravelling the necessary steps to take a diagnostic tool all the way through to companion diagnostic approvalRead more

day: Clinical Implications of Novel Immuno-Oncology Biomarkers

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.